Search – Page 236 – Indianapolis Business Journal

Home » Search

Articles

Hospitals back on construction spree

October 1, 2015

Health care providers say they can’t attract patients tomorrow with facilities from yesterday. So they are scrambling to erect new structures that are more convenient.

BOHANON & STYRING: Is there a teacher shortage? It’s not that simple

October 1, 2015

Does Indiana face a shortage of schoolteachers? You’d certainly think so from news stories showing an 18-percent decline in new teacher licenses issued over the past five years.

Lilly Endowment gives $2.9M more to BioCrossroads

October 1, 2015

Including the latest grant, the Lilly Endowment has given more than $38 million to BioCrossroads since the life sciences business development group was founded in 2002.

Shelbyville firm pays $8.6M for North Meridian office park

September 30, 2015

Evergreen Investment Corp. bought the four-building Waterplace Park from Indianapolis-based Keystone Realty Group, which purchased the property out of receivership in January 2014.

Anthem says industry flush with competition, but local experts have doubts

September 28, 2015

After Anthem CEO Joe Swedish argued that his $54 billion purchase of Cigna Corp. wouldn’t harm competition, execs at some of Indiana’s most prominent health care and health insurance institutions expressed skepticism last week during the IBJ Health Care Power Breakfast.

Settlement clears way for Lilly to launch once-a-day insulin

September 28, 2015

The settlement with France-based Sanofi SA clears up uncertainty over a drug that could rack up more than $1 billion in sales by 2020, according to Wall Street analysts.

The Interview Issue: John Lechleiter

September 24, 2015

John Lechleiter, CEO of Eli Lilly and Co., said the company remained confident about its drug pipeline even after it weathered a string of failed clinical trials.

The Interview Issue: Eugene White

September 24, 2015

Eugene White, the president of Martin University, had become restless in retirement when the opportunity to lead the struggling black liberal arts college surfaced.

The Interview Issue: Paul Baltzell

September 24, 2015

Paul Baltzell, the state of Indiana's chief information officer, is excited about the power of data analytics to improve the effectiveness of government.

The Interview Issue: David Contis

September 24, 2015

Simon Property Group executive David Contis says technology will enhance, not kill, bricks-and-mortar retail.

The Interview Issue: Crystal Grave

September 24, 2015

Crystal Grave, CEO of the event-planning search engine Snappening, gained new perspective on the Indy tech community after spending time in Silicon Valley.

Applications to Marian medical school keep rising

September 24, 2015

With the number of applications to Marian’s College of Osteopathic Medicine running twice as high as initially expected, school leaders say they are confident Marian can help reduce a looming physician shortage in Indiana.

Clinton promises health insurance merger scrutiny in plan

September 24, 2015

Hillary Clinton said she would give close scrutiny to health-insurance industry mergers like those proposed this year by Anthem Inc. and Aetna Inc., part of the Democratic presidential candidate’s latest policy plans.

Analyst: Lilly’s Jardiance diabetes pill could be a $6 billion-a-year blockbuster

September 21, 2015

It looks like Eli Lilly and Co. finally has a drug that can replace its former stars Zyprexa and Cymbalta. The most bullish analysts think Jardiance can surpass those $5 billion-a-year blockbusters.

LOU’S VIEWS: At ATI, a ‘Fantasticks’ worth remembering

September 18, 2015

Requiring a delicate balance of whimsy, theatrics and sincerity, the musical has its problems. But it can thrive when planted in the proper theater and given appropriate watering.

MORRIS: Mayors remind us of path to progress

September 18, 2015

GIPC birthday brought together city leaders who knew how to achieve, in spite of politics.

Jardiance study lifts Lilly shares to 15-year high

September 18, 2015

Eli Lilly shares soared Thursday after study results showed Jardiance sharply reduced chances of dying in diabetic patients at high risk of heart complications. The study prompted at least one analyst to predict the drug could bring in billions of dollars by the end of the decade.

BOHANON & STYRING: Worries about looming deflation are overblown

September 17, 2015

Near-zero interest rates were supposed to pep up the economy. Six years and 10 months later, economic growth has been positive, but anemic. The unemployment rate has fallen to 5.1 percent, but labor force participation rates are at record lows and full-time jobs are hard to find.

Lilly shares jump on latest data from diabetes drug

September 17, 2015

A diabetes pill called Jardiance sold by Eli Lilly and Co. cut deaths from heart attacks and strokes in thousands of patients, the first drug to show promise in helping subdue two of the world’s most rampant health epidemics.

Historic downtown office building sold for $9 million

September 17, 2015

Minneapolis-based Onward Investors LLC has purchased the 93-year-old building on East Washington Street and is planning a major renovation. The new owner hopes to attract a restaurant to the first floor.

« Previous 1 … 234 235 236 237 238 … 367 Next »

Search Results

7,332 results for 'Search IBJ.com'

Articles

Hospitals back on construction spree

BOHANON & STYRING: Is there a teacher shortage? It’s not that simple

Lilly Endowment gives $2.9M more to BioCrossroads

Shelbyville firm pays $8.6M for North Meridian office park

Anthem says industry flush with competition, but local experts have doubts

Settlement clears way for Lilly to launch once-a-day insulin

The Interview Issue: John Lechleiter

The Interview Issue: Eugene White

The Interview Issue: Paul Baltzell

The Interview Issue: David Contis

The Interview Issue: Crystal Grave

Applications to Marian medical school keep rising

Clinton promises health insurance merger scrutiny in plan

Analyst: Lilly’s Jardiance diabetes pill could be a $6 billion-a-year blockbuster

LOU’S VIEWS: At ATI, a ‘Fantasticks’ worth remembering

MORRIS: Mayors remind us of path to progress

Jardiance study lifts Lilly shares to 15-year high

BOHANON & STYRING: Worries about looming deflation are overblown

Lilly shares jump on latest data from diabetes drug

Historic downtown office building sold for $9 million